• 생명과학회지
• /
• 제23권8호
• /
• pp.1050-1056
• /
• 2013

Streptococcus pneumoniae는 전 세계적으로 급성 호흡기 질환 높은 사망률 나타내며, 정상인의 비인후부에 존재하여 호흡기 감염을 통해 폐렴, 수막염, 중이염, 패혈증, 복막염, 골수염 등을 일으킨다. 그러나 S. pneumoniae가 폐 조직에 침입하는 분자적 메커니즘과 혈류를 통한 침입은 많은 연구에도 불구하고 아직 명확하게 알려지지 않았다. 그러므로 본 실험에서는 S. pneumoniae D39의 감염 및 침입에 대한 분자 메카니즘을 알고자 사람의 폐암상피 세포 유래 A549 세포를 이용하여 감염 후 시간의 경과에 따라 변화되는 A549 세포의 모양을 관찰하였으며, 또한 숙주세포의 단백질 패턴 변화를 조사하였다. 일부 A549 세포는 감염 후 2 시간부터 세포의 모양이 둥근형태로 변화된 것으로 관찰되었으며, 감염 3 시간째에는 세포의 모양이 둥글며 filopodia가 아주 잘 발달하였다. 감염 4 시간에 도달하게 되면 거의 모든 A549 세포가 둥글며 잘 발달된 filopodia를 형성하였다. 감염 후 각 시간 별 A549 세포의 총 단백질들을 추출하여 시간의 경과에 따라 특이적으로 양 적인 변화를 나타내는 단백질을 MALDI-TOF 분석법을 사용하여 동정하였다. Streptococcus pneumoniae D39 감염 후 시간에 따라 변화하는 단백질 중 대다수가 특이하게도 molecular chaperone에 속하는 단백질들이었다. 대표적인 cytosol chaperone인 Hsp90과 Hsp70의 경우 감소하는 패턴을 나타낸 반면에 endoplasmic reticulum (ER)에 존재하는 chaperone인 Grp94와 Grp78 (BiP)은 감염 후 점차 증가하는 패턴을 나타내었다. ER chaperone인 Grp94와 Grp78의 증가는 ER stress signaling pathway와 관련 있는 것으로 알려져 있어, S. pneumoniae D39의 감염에 의한 이들 단백질의 변화 패턴을 ER stress를 유발 시켰을 때와 비교하였다. Tunicamycin 또는 thapsigargin으로 처리하여 ER stress를 유발시킨 A549 세포의 형태는 변화하지 않았으며 흡착세포의 형태를 유지하였다. 그러나 Western blot을 통한 molecular chaperone의 분석 결과는 S. pneumoniae D39 감염의 경우와 일치하였다. 본 연구에서 얻은 결과는 S. pneumoniae D39의 감염은 A549 세포의 형태적 변화를 유발하며 또한 molecular chaperone 증가와 감소를 유발한다는 것을 보여주며, 특이적으로 Grp94와 Grp78이 증가되는 것으로 보아 S. pneumoniae D39 감염은 A549 세포 내 ER stress를 유발한다고 생각된다.

• 생명과학회지
• /
• 제16권5호
• /
• pp.746-749
• /
• 2006

구절초 전초의 chloroform 분획물로부터 2종의 flavonoid화합물을 분리하여 NMR을 통해서 구조를 확인한 결과, luteolin (1)과 acacetin (2)으로 구조 동정되었다. 이들의 화합물 중에서 luteolin (1)은 구절초에서 처음으로 분리하였다. 분리된 화합물은 sulforhodamine B (SRB) assay법에 따라 인체암세포주인, HCT116 (결장암) , UO-31 (신장암), PC-3 (전립선암) 와 A549 (폐암)등에 대한 in vitro에서의 세포독성을 실험하였다. 그 결과, acacetin (2)이 HCT116 $(IC_{50}\;2.44\;{\mu}g/ml)$과 UO-31 $(IC_{50}\;2.89\;{\mu}g/ml)$에서 유의할만한 세포독성을 나타내었다.

• Journal of Preventive Medicine and Public Health
• /
• 제35권1호
• /
• pp.13-23
• /
• 2002

Objectives : To investigate the therapeutic compliance and its related factors in lung cancer patients. Methods : The subjects of this study comprised 277 patients first diagnosed with lung cancer at Kyungpook National University Hospital between Jan 1999 and Sept 1999. Of these, 141(50.9%) participated in the study by properly replying to structured questionnaires. The data was analyzed using a simplified Health Decision Model. This model includes categories of variables covering therapeutic compliance, health beliefs, patient preferences, knowledge and experience, social interaction, sociodemographic and clinical characteristics. Results : The therapeutic compliance rate of the 141 study subjects was 78.0%. An analysis of health beliefs and patient preferences revealed health concern (p<0.05), dependency on medicine (p<0.05), perceived susceptibility and severity (p<0.05) as well as preferred treatment (p<0.01) as factors related to therapeutic compliance. Factors from the sociodemographic characteristics and clinical factors that were related to therapeutic compliance were age (p<0.01), monthly income (p<0.05), histological type (p<0.05) and clinical stage (p<0.05) of cancer. Conclusions : In order to improve therapeutic compliance in lung cancer patients it is necessary to educate the aged, low-income patients, or patients who have small cell lung cancer or lune cancer of an advanced stage for which surgery is not indicated. Additionally, it is essential for medical personnel to have a deep concern about patients who have poor lifestyles, a low dependency on medicine, or a high perceived susceptibility and severity. Practically, early diagnosis of lung cancer and thoughtful considerations of low-income patients are important. By means of population-based education in a community, we may promote attention to health and enhance the early diagnosis of lung cancer.

• Radiation Oncology Journal
• /
• 제5권2호
• /
• pp.111-117
• /
• 1987

암 환자에 있어서 영양상태는 치료에 대한 반응과 생존기간에 영향을 미치는 인자가 된다. 그래서 연하곤란은 암 환자에 중요한 영향을 끼친다고 할 수 있다. 저자들은 1983년 3월부터 1987년 3월까지 가톨릭의대 강남성모병원 방사선치료실에서 방사선 치료를 받은 1,400명의 환자 중 연하곤란 및 호흡기계 문제로 방사선 치료를 받았던 식도암 이외의 암에 의한 식도의 헙착 및 폐쇄를 일으킨 환자 16예를 대상으로 이들의 특성과 식도의 협착 및 폐쇄에 대한 방사선 치로의 효과 및 생존기간을 후향성으로 분석하여 보았다. 1. 방사선치료를 받은 환자 중 빈도는 $1\%$이었다. 2. 가장 빈번한 원인은 폐암 (14/16)이었고, 식도 중부 (14/16)가 가장 흔하게 침범되는 부위였다. 3. 방사선 치료에 대한 반응은 연하곤란의 정도와 2주 간격으로 촬영한 바륨조영사진으로 평가하였는데 계획된 방사선 치료를 종료한 환자들의 $80\%$(8/10)에서 반응을 보였다. 4. 반응이 시작되는 선량은 1,000cGy-6,010cGy의 범위에 들어 있으며 중앙치는 2,880cGy였고 평균치는 2,993 cGy였다. 5. Kaplan-Meier 방식에 의한 15주와 30주 생존율은 전예에서는 $60\%$와 $46\%$였고 계획된 방사선 치료를 종료한 환자들에서는 $77\%$와 $51\%$였다. 6. 4예에서는 연하곤란의 재발 없이 90주 이상 생존하고 있다.

• Radiation Oncology Journal
• /
• 제15권4호
• /
• pp.387-392
• /
• 1997

목적 : ICRU 50의 권고에 따라 치료 범위를 Planning Target Volume(PTV)으로 설정하고 있다. 진단 영상장치의 발달과 특히 CT Simulator 등의 도움으로 Gross Tumor Volume(GTV) 설정은 쉬워지고 있으나, 내부장기의 움직임에 의한 경계의 선정에 대하여는 특별한 지침이 없고, 단지 경험에 의존하고 있는 실정이다. 본 연구에서는 폐의 움직임 유형을 분석하여 폐 부위의 PTV설정시 폐의 움지임을 고려쓿기 위한 정량적인 지침을 마련하려는데 있다. 대상 및 방법 : 폐암, 식도암 등 폐 및 흥부 주변의 방사선으로 치료받는 환자 10명을 대상으로 Simulator 투시 촬영기로 폐의 움직임을 관찰하였다. 우측 폐는 12부위와, 좌측 폐는 10부위로 각각 나누었다 우측 폐 부위는 상엽은 2부분, 중엽은 2부분, 하엽은 2부분으로.나누었고, 그 각각을 측면에서 전, 후 2부분으로 나누었다. 좌측 폐 부위는 상엽, 하엽 모두 2부분으로 나누고, 측면에서 다시 전, 후로 다시 2부분으로 나누었다. 부위마다 4-5점을 택해 X선 투시 장치에서 생성된 열상을 컴퓨터에 입력시켜 폐포의 움직임을 x, y, z 3좌표 방향으로 수치화 하였다. 결과 :우측과 좌측 폐 부위 중 안측 상엽 부위의 움직임이 상대적으로 적었으며, 좌우 이동이 전후 이동에 비해 크게 나타났다. 좌우 이동은 심장 박동 효과로 심장 또는 대동맥 근처에서 가장 두드러지게 나타나서 양측 패문 부위가 가장 큰 이동을 보였으며(평균 6.6mm), 상하 이동은 호흡 효과로 양측 폐 하엽 부위, 횡격막 근처에서 가장 컸다(평균 14.1mm). 결론 : X선 투시로 폐의 움직임을 관찰할 수 있으며 컴퓨터의 궤적 추적으로 정량화 할 수 있었다. 폐 부위의 방사선 치료시 설정되는 PTV에는 장기의 움직임을 고려해야 하는데 본 연구의 결과를 이용하여 치료 부위에 따라 여유를 차등을 둔다면 치료 조사면을 최적화 하는데 도움이 될 것으로 생각된다.

• 대한한방내과학회지
• /
• 제28권3호
• /
• pp.473-491
• /
• 2007

Objectives : This study was designed to investigate the antiproliferative activity of the water extract of Samgibopae-tang (SGBPT) in NCI-H460 and A549 non-small-cell lung cancer cell lines Methods : In this study, we measured the subsistence, form of NCI-H460 and A549 non-small-cell lung cancer cell by hemocytometer and DAPI staining. In each cell, we analyzed DNA fragmentation. reverse transcription-polymerase chain reaction and measured activity of caspase-3, caspase-8 and caspase-9. Results and Conclusions : We found that exposure of A549 cells to SGBPT resulted in growth inhibition in a dose-dependent manner. butSGBPT did not affect the growth of NCI-H460 cells. The antiproliferative effect by SGBPT treatment in A549 cells was associated with morphological changes. SGBPT treatment partially induced the expression of DR5 cells and the expression of Faswas markedly increased in both transcriptional and translational levels in A549 cells. SGBPT treatment partially induced the expression of Bcl-2, Bcl-XL and the expression of Bid was markedly decreased in translational levels in A549 cells. However, SGBPT treatment did not affect the expression of IAP family in A549 orNCI-H460 cells. SGBPT treatment partially induced the expression of caspase-3, caspase-8, caspase-9 activity which markedly increased in a dose-dependent manners in A549 cells. The fragmental development of PARP and ${\beta}$-catenin protein was observed in A549 cells by SGBPT treatment. SGBPT treatment induced the expression of PLC-${\gamma}1$ protein which decreased in A549 cells. SGBPT treatment partially induced the expression of DFF45/ICAD which markedly increased in a dose-dependent manner in A549 cells. Taken together. these findings suggested that SGBPT-induced inhibition of human lung carcinoma did not affect NCI-H460 cell growth. However, SGBPT-induced inhibition of human lung carcinoma A549 cell growth was associated with the induction of death receptor and mitochondrial pathway. The results provided important new insights into the possible molecular mechanisms of the anti-cancer activity of SGBPT.

• 동의생리병리학회지
• /
• 제19권5호
• /
• pp.1204-1212
• /
• 2005

Lung cancer is one of the common malignant tumors in the world. It occurs more increasingly due to the serious air pollution, heavy smoking, expoure to ionized radiation, pollution with heavy metal, and owing to well advanced diagnostic skill, etc. Also lung cancer has the limitation of medical care because metastasis is already shown up in more than half cases when it is first detected through medical examination. Although it is treated with chemoradiation, the rate of deaths from lung cancer is high as well, because blood has a lot of toxicity which give side effects. So it has a low rate of cure. So, the ways of various treatment is being researched to raise the rate of care and decrease the side effects recently, and one of the results is inducing apoptosis which makes use of molecularbiologic diagnosis of lung cancer's cell and using oriental medicine drugs. The purpose of this study is whether apoptosis would happen on the human lung carcinoma cell by treated with Junglyeokdaejosape-tang, Junglyeok-tang Junglyeokdaejosape-tang and Junglyeok-tang has been prescribed for cough, chest pain, and many other similar cases. Cough and chest pain is shown in early lung cancer. That is why we used these prescriptions. Apoptosis happend on the human lung carcinoma A549 cells treated with Jeongiyeokdaejosapye-tang, Jeonglyeok-tang. The concentration-dependent inhibition of cell viability was observed and apoptosis was confirmed by DNA fragmentation. Bcl-2 and COX-2 mRNA expression decreased, but Bax mRNA expression increased, so it was identified with the case of indomethacin known to enhance apoptotic DNA fragmentation. Also expression of the p21, p53, cyclin E, cyclin D1, cytochrome c, caspase-3, and caspase-9 protein increased and the activity of caspase-3 increased, as well. Last, fragmentation of the PARP was shown. The previous and present results indicated that apoptosis of A549 cells by above-mentioned drugs is associated with the blockage of G1/S progression.

• 동의생리병리학회지
• /
• 제24권2호
• /
• pp.272-277
• /
• 2010

This experimental study was performed to investigate the antitumor effect of Egg white combined-Chalcanthite (InSan 4, IS4) in xenografted nude mice with NCI-H460 human lung cancer cell. We cultured NCI-H460 cell lines and xenografted them on nude mice. These mice were divided into 3 groups; group with dose of 45 mg/kg IS4 orally, group with dose of 90 mg/kg IS4 orally, and the control group. They had been raised and treated for 28 days. We checked their body weight, tumor weight and volume twice a week, and their absolute organ weight, microhistological observation and biochemical blood analysis at the final day by sacrificing them. We also calculated their tumor inhibition rate (IR), mean survival time and percent increase in life span (% ILS). In this study, we observed that all of the IS4 treated mice have tumor regression, dosage-dependently, compared to the control group. Tumor weight and volume of high dose treated mice were smallest. IR increased in IS4 in a dose-dependent manner. Mean survival time and percent increase in life span (% ILS) in high-dose IS4 treatment group were the highest of the three groups. There was no significant difference in biochemical blood analysis, alanine phopsphatase (ALP), Calcium, creatinine (CRE), alanine transferase (ALT), and aspartate transaminase (AST) levels. The urea nitrogen (UN) level results significantly decreased by IS4 45 and 90 mg/kg (IS4 45 mg/kg, IS4 90 mg/kg, p<0.01). IS4 may have potential anti-tumor effect in a solid tumor induced by NCI-H460 without remarkable side effects.

• 동의생리병리학회지
• /
• 제28권6호
• /
• pp.689-694
• /
• 2014

We report a female small cell lung cancer patient in the extensive stage(T3N3Mx). After 6 cycles of chemotherapy combined radiation therapy, she received inpatient Korean medical care including herbal medicine, acupuncture therapy and concurrent western oral medications of opioid analgesics and anti-anxiety agent. The chief complaint was right side thoracic wall pain which had started after chemotherapy and was not effectively controlled by analgesics. For this condition, we treated her with 2Hz of constant electrical stimulation on Jiaji (Ex-B2) points T5-T7 laterally (right) using three needles for 20 minutes once a day for 9 days. With every session of electrical acupuncture treatment, thoracic pain decreased acutely. Korean medicine treatments including Jiaji (Ex-B2) point stimulation might be tried for lung cancer patients with uncontrolled thoracic pain at least for the acute analgesic effect.

• Journal of Chest Surgery
• /
• 제25권1호
• /
• pp.86-95
• /
• 1992

We have performed surgical operations for 184 primary lung carcinomas over a 10 year period from December, 1979 to December, 1990 at the department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea. We have reviewed 77 cases confirmed to be dead in the post-operative follow-up period among 184 cases. There were 68 males and 9 females [M: F=7.56: 1], with 76.62% ranging between 50 to 70 years old There were 50 cases[64.94%] of squamous cell carcinoma, 15[19.48%] of adenocarcinoma, 4[5.19%] of large cell carcinoma, 4[5.19%] of mixed cell carcinoma 3 [3.90%] of small cell carcinoma % 1 case of bronchoalveolar cell carcinoma. There were 25 cases[32.47%] in stage I, 12 [15.58%] in stage II 32 [41.56%] in stage IIIa and 8 [10.39%] in stage IIIb according to the new international staging system for lung cancer. The operative methods were left pneumonectomy in 38 cases, right pneumonectomy in 21, bilobectomy in 5, lobectomy in 12, and wedge resection in one case.ase. There were 9 operative mortalities; one case by bleeding, 5 cases by respiratory failure, one case by bleeding & renal failure, one case by empyema thoracis with BPF and one case by brain metastases. The actuarial mean survival length was 14.636$\pm$18.188months overall and 16.441$\pm$18. 627months in 68 cases excluding 9 operative deaths. The actuarial mean survival length was 18.568$\pm$11.057 months in 43 squamous cell carcinomas, 14.385$\pm$11.057 months in 14 adenocarcinomas, 10.250$\pm$8.884months in 4 large cell carcinomas and 12.250$\pm$17.193months in 4 mixed cell carcinomas. The actuarial mean survival length was 14.051$\pm$16.963months in 59 pneumonectomy cases, 15.200$\pm$12.478 months in 5 bilobectomy cases, 18.417$\pm$26.026months in 12 lobectomy cases. The actuarial mean survival length was 28.952$\pm$25.738months in 22 stage I cases, 19. 455$\pm$16.723months in ll stage II cases, 8.633$\pm$6.584months in 29 stage IIIa cases and 6. 167$\pm$4.355months in 6 stage IIIb cases. The differences of actuarial mean survival length according to the stages were statistically significant [a=0.003]